225 related articles for article (PubMed ID: 26883194)
1. Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.
Kim N; Cho A; Watanabe H; Choi YL; Aziz M; Kassner M; Joung JG; Park AK; Francis JM; Bae JS; Ahn SM; Kim KM; Park JO; Park WY; Ahn MJ; Park K; Koo J; Yin HH; Cho J
Oncotarget; 2016 Mar; 7(12):13797-809. PubMed ID: 26883194
[TBL] [Abstract][Full Text] [Related]
2. Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib.
Amri J; Molaee N; Baazm M; Karami H
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2781-2787. PubMed ID: 31554377
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models.
Ito K; Semba T; Uenaka T; Wakabayashi T; Asada M; Funahashi Y
Cancer Sci; 2014 Aug; 105(8):1023-31. PubMed ID: 24841832
[TBL] [Abstract][Full Text] [Related]
4. BMSC-derived leptin and IGFBP2 promote erlotinib resistance in lung adenocarcinoma cells through IGF-1R activation in hypoxic environment.
Wang F; Zhang L; Sai B; Wang L; Zhang X; Zheng L; Tang J; Li G; Xiang J
Cancer Biol Ther; 2020; 21(1):61-71. PubMed ID: 31559898
[TBL] [Abstract][Full Text] [Related]
5. Up-Regulation of MiRNA-125a-5p Inhibits Cell Proliferation and Increases EGFR-TKI Induced Apoptosis in Lung Cancer Cells.
Amri J; Molaee N; Karami H
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3361-3367. PubMed ID: 31759360
[TBL] [Abstract][Full Text] [Related]
6. EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.
Yang C; Ma S; Zhang J; Han Y; Wan L; Zhou W; Dong X; Yang W; Chen Y; Gao L; Cui W; Jia L; Yang J; Wu C; Wang Q; Wang L
Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2317790121. PubMed ID: 38814866
[TBL] [Abstract][Full Text] [Related]
7. Alginate microspheres encapsulating hox transcript antisense RNA siRNA regulate the Hedgehog-Gli1 pathway to alleviate epidermal growth factor receptor tyrosine kinase inhibitors resistance.
Lu G; Zhong H; Gao J; Zhang Y
J Biomater Appl; 2024 Mar; 38(8):877-889. PubMed ID: 38261797
[TBL] [Abstract][Full Text] [Related]
8. Monolayer culture alters EGFR inhibitor response through abrogation of microRNA-mediated feedback regulation.
Florio A; Johnson S; Salvatori R; Vasmatzis G
Sci Rep; 2024 Mar; 14(1):7303. PubMed ID: 38538642
[TBL] [Abstract][Full Text] [Related]
9. LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells.
Whang YM; Park SI; Trenary IA; Egnatchik RA; Fessel JP; Kaufman JM; Carbone DP; Young JD
Oncogene; 2016 Feb; 35(7):856-66. PubMed ID: 26119936
[TBL] [Abstract][Full Text] [Related]
10. Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoids.
Banda M; McKim KL; Myers MB; Inoue M; Parsons BL
PLoS One; 2020; 15(9):e0238862. PubMed ID: 32898185
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog pathway maintains cell survival under stress conditions, and drives drug resistance in lung adenocarcinoma.
Lin EH; Kao YR; Lin CA; Kuo TY; Yang SP; Hsu CF; Chou TY; Ho CC; Wu CW
Oncotarget; 2016 Apr; 7(17):24179-93. PubMed ID: 27015549
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of intrinsic resistance of lung squamous cell carcinoma to epithelial growth factor receptor-tyrosine kinase inhibitors revealed by high-throughput RNA interference screening.
Ju L; Dong Z; Yang J; Li M
Oncol Lett; 2020 Dec; 20(6):363. PubMed ID: 33133263
[TBL] [Abstract][Full Text] [Related]
13. Targeting K
Todesca LM; Gerke M; Bulk EE; Bachmann M; Rudersdorf A; Antonuzzo L; Pillozzi S; Düfer M; Szabo I; Schwab A
Cell Death Discov; 2024 Jan; 10(1):2. PubMed ID: 38177097
[TBL] [Abstract][Full Text] [Related]
14. Using functional genomics to overcome therapeutic resistance in hematological malignancies.
Alvarez-Calderon F; Gregory MA; DeGregori J
Immunol Res; 2013 Mar; 55(1-3):100-15. PubMed ID: 22941562
[TBL] [Abstract][Full Text] [Related]
15. Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.
Willers H; Azzoli CG; Santivasi WL; Xia F
Cancer J; 2013; 19(3):200-7. PubMed ID: 23708066
[TBL] [Abstract][Full Text] [Related]
16. Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer.
Sin TK; Wang F; Meng F; Wong SC; Cho WC; Siu PM; Chan LW; Yung BY
Int J Mol Sci; 2016 Feb; 17(2):237. PubMed ID: 26891293
[TBL] [Abstract][Full Text] [Related]
17. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
Jang JY; Kim YG; Nam SJ; Keam B; Kim TM; Jeon YK; Kim CW
Mol Cancer Ther; 2016 Jun; 15(6):1387-96. PubMed ID: 26883272
[TBL] [Abstract][Full Text] [Related]
18. Molecular targeted therapy to improve radiotherapeutic outcomes for non-small cell lung carcinoma.
Bhardwaj B; Revannasiddaiah S; Bhardwaj H; Balusu S; Shwaiki A
Ann Transl Med; 2016 Feb; 4(3):50. PubMed ID: 26904572
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the lung with concomitant ALK fusion gene and EGFR gene mutation: A case report and literature review.
Fan T; Song YJ; Liu XL
Mol Clin Oncol; 2016 Feb; 4(2):203-205. PubMed ID: 26893862
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydrothorax EGFR gene mutation and EGFR-TKI targeted therapy on advanced non-small cell lung cancer patients.
Zhou BO; Nie J; Yang W; Huang C; Huang YE; Zhao H
Oncol Lett; 2016 Feb; 11(2):1413-1417. PubMed ID: 26893752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
